These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2879453)

  • 1. Role of a long-acting somatostatin analogue (SMS 201-995) in the treatment of acromegaly.
    Jackson IM; Barnard LB; Lamberton P
    Am J Med; 1986 Dec; 81(6B):94-101. PubMed ID: 2879453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SMS 201-995 induces a continuous decline in circulating growth hormone and somatomedin-C levels during therapy of acromegalic patients for over two years.
    Lamberts SW; Uitterlinden P; del Pozo E
    J Clin Endocrinol Metab; 1987 Oct; 65(4):703-10. PubMed ID: 2888785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of resistant acromegaly with a long-acting somatostatin analogue (SMS 201-995).
    Barnard LB; Grantham WG; Lamberton P; O'Dorisio TM; Jackson IM
    Ann Intern Med; 1986 Dec; 105(6):856-61. PubMed ID: 2877605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sensitivity of growth hormone and prolactin secretion to the somatostatin analogue SMS 201-995 in patients with prolactinomas and acromegaly.
    Lamberts SW; Zweens M; Klijn JG; van Vroonhoven CC; Stefanko SZ; Del Pozo E
    Clin Endocrinol (Oxf); 1986 Aug; 25(2):201-12. PubMed ID: 2878748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-acting and selective suppression of growth hormone secretion by somatostatin analogue SMS 201-995 in acromegaly.
    Plewe G; Beyer J; Krause U; Neufeld M; del Pozo E
    Lancet; 1984 Oct; 2(8406):782-4. PubMed ID: 6148524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995.
    Lamberts SW; Uitterlinden P; Verschoor L; van Dongen KJ; del Pozo E
    N Engl J Med; 1985 Dec; 313(25):1576-80. PubMed ID: 2866445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995 over 6 months.
    Plewe G; Schrezenmeir J; Nölken G; Krause U; Beyer J; Kasper H; del Pozo E
    Klin Wochenschr; 1986 Apr; 64(8):389-92. PubMed ID: 2871221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of SMS 201-995, a long-acting somatostatin analogue, on the secretion and morphology of a pituitary growth hormone cell adenoma.
    George SR; Kovacs K; Asa SL; Horvath E; Cross EG; Burrow GN
    Clin Endocrinol (Oxf); 1987 Apr; 26(4):395-405. PubMed ID: 2888549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of acromegaly with the long-acting somatostatin analog SMS 201-995.
    Barkan AL; Kelch RP; Hopwood NJ; Beitins IZ
    J Clin Endocrinol Metab; 1988 Jan; 66(1):16-23. PubMed ID: 2891720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical treatment of acromegaly: comorbidities and their reversibility by somatostatin analogs.
    Tolis G; Angelopoulos NG; Katounda E; Rombopoulos G; Kaltzidou V; Kaltsas D; Protonotariou A; Lytras A
    Neuroendocrinology; 2006; 83(3-4):249-57. PubMed ID: 17047390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical management of acromegaly: effects of SMS 201-995 in 30 patients.
    Pagani G; Montini M; Gianola D; Pagani MD; Tengattini F; Dominoni P; Ghilardi G; Cortesi L; Pedroncelli A; Tonnarelli GP
    Endocrinol Exp; 1990 Mar; 24(1-2):175-85. PubMed ID: 2361459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy of the somatostatin analog SMS 201-995 (octreotide) in acromegaly. Effects of dose and frequency and long-term safety.
    Ho KY; Weissberger AJ; Marbach P; Lazarus L
    Ann Intern Med; 1990 Feb; 112(3):173-81. PubMed ID: 2404445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and biochemical effects of incremental doses of the long-acting somatostatin analogue SMS 201-995 in ten acromegalic patients.
    Shi YF; Harris AG; Zhu XF; Deng JY
    Clin Endocrinol (Oxf); 1990 Jun; 32(6):695-705. PubMed ID: 2200620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shrinking of a growth hormone-producing pituitary tumor by continuous subcutaneous infusion of the somatostatin analog SMS 201-995.
    Ducasse MC; Tauber JP; Tourre A; Bonafe A; Babin T; Tauber MT; Harris AG; Bayard F
    J Clin Endocrinol Metab; 1987 Nov; 65(5):1042-6. PubMed ID: 2889748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acromegaly from ectopic growth hormone-releasing hormone secretion by a malignant carcinoid tumor. Successful treatment with long-acting somatostatin analogue SMS 201-995.
    Barkan AL; Shenker Y; Grekin RJ; Vale WW
    Cancer; 1988 Jan; 61(2):221-6. PubMed ID: 2891432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a single administration of somatostatin analogue (SMS 201-995) on GH, TSH and insulin secretion in patients with acromegaly.
    Horikawa R; Takano K; Hizuka N; Asakawa K; Shibasaki T; Masuda A; Shizume K
    Endocrinol Jpn; 1986 Dec; 33(6):743-9. PubMed ID: 2884093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective long-term treatment of acromegaly with a long-acting somatostatin analogue (SMS 201-995).
    Sandler LM; Burrin JM; Williams G; Joplin GF; Carr DH; Bloom SR
    Clin Endocrinol (Oxf); 1987 Jan; 26(1):85-95. PubMed ID: 2879656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NIH conference. Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut.
    Gorden P; Comi RJ; Maton PN; Go VL
    Ann Intern Med; 1989 Jan; 110(1):35-50. PubMed ID: 2535688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses.
    Pieters GF; van Liessum PA; Smals AG; van Gennep JA; Benraad TJ; Kloppenborg PW
    Acta Endocrinol Suppl (Copenh); 1987; 286():9-18. PubMed ID: 2892339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of gender and gonadal status on the long-term response to somatostatin analogue treatment in acromegaly.
    Colao A; Pivonello R; Cappabianca P; Briganti F; Tortora F; Auriemma RS; De Martino MC; Marzullo P; Lombardi G
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):342-9. PubMed ID: 16117824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.